Starting a medication for primary biliary cholangitis (PBC) can bring hope as well as questions and concerns.

Iqirvo is a formulation of elafibranor approved by the U.S. Food and Drug Administration (FDA) for certain adults with PBC. It may be used when ursodeoxycholic acid (UDCA, also called ursodiol) doesn’t work well enough or can’t be tolerated. Iqirvo may be used with UDCA when UDCA alone doesn’t work well enough, or by itself when a person can’t tolerate UDCA.

The FDA’s accelerated approval was based on a reduction in alkaline phosphatase (ALP).

Members of myPBCteam have shared what it’s like to take Iqirvo, including changes in ALP levels, symptoms during treatment, and challenges with side effects and access.

For more on Iqirvo, including how to take it, side effects, and advice from other members, check out this treatment article.

Here are five questions myPBCteam members have raised about taking Iqirvo.

A decrease in ALP is one important sign doctors use to assess whether Iqirvo is working. Doctors may also monitor bilirubin and other liver tests to see how someone is responding to treatment.

Some members reported substantial changes after starting the medication.

One shared, “I just got the latest lab tests back, and the Iqirvo is working. After 30 days, my ALP came down from 216 to 94. For the first time in six years, it’s in the normal range.”

Another said, “My alkaline phosphatase is in the normal range thanks to Iqirvo!!! My numbers have dropped dramatically at the six-week mark, and I am so happy to see it.”

“My alkaline phosphatase is in the normal range thanks to Iqirvo!!! My numbers have dropped dramatically at the six-week mark, and I am so happy to see it.”

 

— A myPBCteam member

These are individual experiences. They don’t establish how much or how quickly someone else’s ALP will change. Your doctor can explain which lab results they’re monitoring and what those results mean for your PBC.

Lab results may change at different rates over time, so one blood test may not tell the whole story. In clinical studies used for approval, ALP levels were lower as early as four weeks and were generally maintained through week 52. Your own timeline may look different.

Some members found themselves wondering what changes in the pace of their results meant.

One myPBCteam member shared, “Numbers went down fast at first, now have slowed down. Is this normal?”

Another reported a mixed picture: “So far, some numbers down, but others up. Doctor says more blood work in six weeks.”

Ask your doctor how often your labs will be checked and how they’ll evaluate your response over time.

Iqirvo’s approval is based on its ability to lower ALP. An improvement in liver tests doesn’t necessarily mean that symptoms will improve in the same way or on the same timeline. In PBC, fatigue and itching are common symptoms, and symptom severity doesn’t always match disease severity.

Some members reported changes in symptoms along with their lab results. One said, “The itching comes and goes for me, but not as much now that I’m on Iqirvo.”

“The itching comes and goes for me, but not as much now that I’m on Iqirvo.”

 

— A myPBCteam member

Another described improvements alongside some ongoing issues: “Taking Iqirvo has done wonders. Blood work back to normal. Yes, I still have some nausea, etc. My other symptoms have improved also. But, still have hair loss.”

Even when a treatment is helping your liver tests, you may still have symptoms or new questions. That’s one reason it can help to track both how you feel and what your lab work shows.

Iqirvo can cause side effects, although each person may experience them differently. The prescribing information lists common side effects such as:

• Weight gain
• Diarrhea
• Abdominal pain
• Nausea
• Vomiting
• Joint pain
• Constipation
• Muscle problems
• Bone fractures
• Reflux
• Dry mouth
• Weight loss
• Rash

The prescribing information also includes warnings about muscle injury, liver injury, and gallstones or bile duct blockage.

One member shared, “I am having some gastrointestinal pain after eating certain foods that I’ve never had before.”

Another said, “I’ve been on Urso for almost two years now and helps bring down my liver numbers. And been on Iqirvo since June 2025. I have sore muscles and bones. I have weight gain as well. Tired more, take it easy, and I don’t overdo it. Extra tired.”

Having a symptom while taking Iqirvo doesn’t necessarily mean the medication caused it. Still, new, severe, or worsening symptoms are worth bringing up with your healthcare provider right away.

Insurance coverage and out-of-pocket costs for Iqirvo can vary from person to person. The manufacturer’s Ipsen Care support program can help people who have been prescribed Iqirvo understand insurance coverage requirements and identify financial assistance programs they may qualify for.

For some members, getting Iqirvo was a challenge of its own. One myPBCteam member wrote, “GI wants me to start Iqirvo, but not covered by insurance. They’re working on it.”

Others described lengthy insurance processes. One said, “It did take a long time and a lot of work from my doctor to get insurance approval. It got denied, and we had to appeal, and then it was approved. But I will have to file for reapproval at the start of every year.”

“It got denied, and we had to appeal, and then it was approved. But I will have to file for reapproval at the start of every year.”

 

— A myPBCteam member

What you pay can depend on your insurance and other factors, so another member’s costs may not reflect your own. If you’re having trouble getting or affording Iqirvo, let your healthcare team know. They may be able to help you understand coverage requirements or point you toward assistance options.

Talk With Your Doctor About What’s Right for You

Living with PBC can involve paying attention to more than one sign of treatment success. Lab results matter, but so do symptoms, side effects, and how treatment fits into everyday life.

The experiences shared on myPBCteam also show how different treatment can look from person to person. Keeping track of your own questions, symptoms, and concerns can help you and your healthcare team have more productive conversations about your PBC care.